T1	Factor 133 137	Risk
T2	AdverseReaction 141 162	Thyroid C-cell Tumors
T3	AdverseReaction 208 226	Acute Pancreatitis
T4	AdverseReaction 272 284	Hypoglycemia
T5	AdverseReaction 387 413	Hypersensitivity Reactions
T6	AdverseReaction 459 475	Renal Impairment
T7	AdverseReaction 655 688	upper respiratory tract infection
T8	AdverseReaction 690 698	diarrhea
T9	AdverseReaction 700 706	nausea
T10	AdverseReaction 708 731	injection site reaction
T11	AdverseReaction 733 738	cough
T12	AdverseReaction 740 749	back pain
T13	AdverseReaction 751 761	arthralgia
T14	AdverseReaction 763 772	sinusitis
T15	AdverseReaction 778 787	influenza
T16	AdverseReaction 2758 2791	Upper respiratory tract infection
T17	AdverseReaction 2867 2875	Diarrhea
T18	AdverseReaction 2976 2982	Nausea
T19	AdverseReaction 3085 3108	Injection site reaction
T20	AdverseReaction 3194 3199	Cough
T21	AdverseReaction 3303 3312	Back pain
T22	AdverseReaction 3412 3422	Arthralgia
T23	AdverseReaction 3521 3530	Sinusitis
T24	AdverseReaction 3630 3639	Influenza
T25	AdverseReaction 4146 4173	gastrointestinal complaints
T26	AdverseReaction 4292 4300	diarrhea
T27	AdverseReaction 4305 4311	nausea
T28	AdverseReaction 4341 4375	gastrointestinal adverse reactions
T29	AdverseReaction 4437 4445	vomiting
T30	AdverseReaction 4493 4524	gastroesophageal reflux disease
T31	AdverseReaction 4576 4585	dyspepsia
T32	AdverseReaction 4633 4645	Constipation
T33	AdverseReaction 4773 4785	GI reactions
T34	Severity 4790 4794	mild
T35	Severity 4814 4822	moderate
T36	Severity 4846 4852	severe
T37	AdverseReaction 4893 4913	GI adverse reactions
T38	AdverseReaction 5046 5070	injection site reactions
T39	AdverseReaction 5159 5182	injection site reaction
T40	AdverseReaction 5294 5317	injection site hematoma
T41	AdverseReaction 5366 5389	injection site erythema
T42	AdverseReaction 5437 5456	injection site rash
T43	AdverseReaction 5502 5533	injection site hypersensitivity
T44	AdverseReaction 5583 5608	injection site hemorrhage
T45	AdverseReaction 5656 5679	Injection site pruritus
T46	AdverseReaction 5751 5775	injection site reactions
T47	Severity 5792 5796	mild
T48	AdverseReaction 5937 5960	injection site reaction
T49	AdverseReaction 2264 2276	hypoglycemia
T50	AdverseReaction 7499 7511	hypoglycemia
T51	AdverseReaction 7686 7706	hypoglycemic episode
T52	AdverseReaction 7782 7802	hypoglycemic episode
T53	Severity 7775 7781	severe
T54	AdverseReaction 7884 7896	Hypoglycemia
T55	AdverseReaction 11603 11615	hypoglycemia
T56	Severity 11596 11602	severe
T58	Negation 11567 11569	no
T59	AdverseReaction 11760 11781	hypoglycemic symptoms
T60	AdverseReaction 11704 11743	Plasma glucose concentration <=70 mg/dL
T61	AdverseReaction 11909 11921	hypoglycemia
T62	AdverseReaction 12085 12094	pneumonia
T63	AdverseReaction 12229 12238	pneumonia
T64	Severity 12275 12282	serious
T65	AdverseReaction 12452 12471	atrial fibrillation
T66	AdverseReaction 12483 12497	atrial flutter
T67	AdverseReaction 12911 12923	appendicitis
T68	Severity 12893 12900	serious
T69	AdverseReaction 14527 14551;14558 14566	alanine aminotransferase increase
T70	AdverseReaction 14776 14788	ALT increase
T71	AdverseReaction 15086 15102	elevation in ALT
T72	AdverseReaction 15162 15189	increase in total bilirubin
T73	AdverseReaction 15295 15316	hepatocellular injury
T74	AdverseReaction 15604 15617	increased GGT
T75	AdverseReaction 16005 16027	increase in heart rate
T76	AdverseReaction 15795 15810;15848 15882	mean heart rate higher by an average of 1 to 2 bpm
T77	AdverseReaction 4021 4045	injection site reactions
T78	AdverseReaction 5227 5251	injection site reactions
T79	Severity 7674 7685	symptomatic
T80	Severity 11581 11592	symptomatic
T57	Severity 11897 11908	symptomatic
T81	AdverseReaction 14553 14556;14558 14566	ALT increase
T82	AdverseReaction 14921 14941	rise in liver enzyme
T83	Negation 14872 14890	alternate etiology
T84	Severity 15104 15138	10 times the upper limit of normal
T85	Severity 15191 15224	4 times the upper limit of normal
E1	Factor:T1
E2	AdverseReaction:T2 Hypothetical:E1
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E34	Severity:T34
E35	Severity:T35
E36	Severity:T36
E38	AdverseReaction:T33 Effect:E36 Effect2:E35 Effect3:E34
E39	AdverseReaction:T37
E40	AdverseReaction:T38
E41	AdverseReaction:T39
E42	AdverseReaction:T40
E43	AdverseReaction:T41
E44	AdverseReaction:T42
E45	AdverseReaction:T43
E46	AdverseReaction:T44
E47	AdverseReaction:T45
E48	AdverseReaction:T46 Effect:E50
E49	AdverseReaction:T46
E50	Severity:T47
E51	AdverseReaction:T48
E52	AdverseReaction:T49
E53	AdverseReaction:T50
E54	AdverseReaction:T51 Effect:E80
E55	AdverseReaction:T52 Effect:E56
E56	Severity:T53
E57	AdverseReaction:T54
E58	AdverseReaction:T55 Effect:E59 Negated:E61 Effect2:E81
E59	Severity:T56
E61	Negation:T58
E62	AdverseReaction:T59
E63	AdverseReaction:T60
E64	AdverseReaction:T61 Effect:E60
E65	AdverseReaction:T62
E66	AdverseReaction:T63 Effect:E67
E67	Severity:T64
E68	AdverseReaction:T65
E69	AdverseReaction:T66
E70	AdverseReaction:T67 Effect:E71
E71	Severity:T68
E72	AdverseReaction:T69
E73	AdverseReaction:T70
E74	AdverseReaction:T71 Effect:E85
E75	AdverseReaction:T72 Effect:E86
E76	AdverseReaction:T73
E77	AdverseReaction:T74
E78	AdverseReaction:T75
E79	AdverseReaction:T76
E33	AdverseReaction:T77
E37	AdverseReaction:T78
E80	Severity:T79
E81	Severity:T80
E60	Severity:T57
E82	AdverseReaction:T81
E83	AdverseReaction:T82 Negated:E84
E84	Negation:T83
E85	Severity:T84
E86	Severity:T85
A1	flag E2 duplicate
A2	CUI E2 C0342190
A3	UMLS-Preferred-Name E2 C-cell hyperplasia of thyroid
A4	MEDDRA-PT E2 Thyroid C-cell hyperplasia
A5	MEDDRA-PT-ID E2 10070568
A6	CUI E3 C0001339
A7	UMLS-Preferred-Name E3 Acute pancreatitis
A8	MEDDRA-PT E3 Pancreatitis acute
A9	MEDDRA-PT-ID E3 10033647
A10	LLT E3 Acute pancreatitis
A11	LLT-ID E3 10000971
A12	CUI E4 C0020615
A13	UMLS-Preferred-Name E4 Hypoglycemia
A14	MEDDRA-PT E4 Hypoglycaemia
A15	MEDDRA-PT-ID E4 10020993
A16	LLT E4 Hypoglycemia
A17	LLT-ID E4 10021005
A18	CUI E5 C0020517
A19	UMLS-Preferred-Name E5 Hypersensitivity
A20	MEDDRA-PT E5 Hypersensitivity
A21	MEDDRA-PT-ID E5 10020751
A22	LLT E5 Hypersensitivity reaction
A23	LLT-ID E5 10020756
A24	CUI E6 C1565489
A25	UMLS-Preferred-Name E6 Renal Insufficiency
A26	MEDDRA-PT E6 Renal impairment
A27	MEDDRA-PT-ID E6 10062237
A28	CUI E7 C0041912
A29	UMLS-Preferred-Name E7 Upper Respiratory Infections
A30	MEDDRA-PT E7 Upper respiratory tract infection
A31	MEDDRA-PT-ID E7 10046306
A32	CUI E8 C0011991
A33	UMLS-Preferred-Name E8 Diarrhea
A34	MEDDRA-PT E8 Diarrhoea
A35	MEDDRA-PT-ID E8 10012735
A36	LLT E8 Diarrhea
A37	LLT-ID E8 10012727
A38	CUI E9 C0027497
A39	UMLS-Preferred-Name E9 Nausea
A40	MEDDRA-PT E9 Nausea
A41	MEDDRA-PT-ID E9 10028813
A42	CUI E10 C0151735
A43	UMLS-Preferred-Name E10 Injection site reaction
A44	MEDDRA-PT E10 Injection site reaction
A45	MEDDRA-PT-ID E10 10022095
A46	CUI E11 C0010200
A47	UMLS-Preferred-Name E11 Coughing
A48	MEDDRA-PT E11 Cough
A49	MEDDRA-PT-ID E11 10011224
A50	CUI E12 C0004604
A51	UMLS-Preferred-Name E12 Back Pain
A52	MEDDRA-PT E12 Back pain
A53	MEDDRA-PT-ID E12 10003988
A54	CUI E13 C0003862
A55	UMLS-Preferred-Name E13 Arthralgia
A56	MEDDRA-PT E13 Arthralgia
A57	MEDDRA-PT-ID E13 10003239
A58	CUI E14 C0037199
A59	UMLS-Preferred-Name E14 Sinusitis
A60	MEDDRA-PT E14 Sinusitis
A61	MEDDRA-PT-ID E14 10040753
A62	CUI E15 C0021400
A63	UMLS-Preferred-Name E15 Influenza
A64	MEDDRA-PT E15 Influenza
A65	MEDDRA-PT-ID E15 10022000
A66	CUI E16 C0041912
A67	UMLS-Preferred-Name E16 Upper Respiratory Infections
A68	MEDDRA-PT E16 Upper respiratory tract infection
A69	MEDDRA-PT-ID E16 10046306
A70	CUI E17 C0011991
A71	UMLS-Preferred-Name E17 Diarrhea
A72	MEDDRA-PT E17 Diarrhoea
A73	MEDDRA-PT-ID E17 10012735
A74	LLT E17 Diarrhea
A75	LLT-ID E17 10012727
A76	CUI E18 C0027497
A77	UMLS-Preferred-Name E18 Nausea
A78	MEDDRA-PT E18 Nausea
A79	MEDDRA-PT-ID E18 10028813
A80	CUI E19 C0151735
A81	UMLS-Preferred-Name E19 Injection site reaction
A82	MEDDRA-PT E19 Injection site reaction
A83	MEDDRA-PT-ID E19 10022095
A84	CUI E20 C0010200
A85	UMLS-Preferred-Name E20 Coughing
A86	MEDDRA-PT E20 Cough
A87	MEDDRA-PT-ID E20 10011224
A88	CUI E21 C0004604
A89	UMLS-Preferred-Name E21 Back Pain
A90	MEDDRA-PT E21 Back pain
A91	MEDDRA-PT-ID E21 10003988
A92	CUI E22 C0003862
A93	UMLS-Preferred-Name E22 Arthralgia
A94	MEDDRA-PT E22 Arthralgia
A95	MEDDRA-PT-ID E22 10003239
A96	CUI E23 C0037199
A97	UMLS-Preferred-Name E23 Sinusitis
A98	MEDDRA-PT E23 Sinusitis
A99	MEDDRA-PT-ID E23 10040753
A100	CUI E24 C0021400
A101	UMLS-Preferred-Name E24 Influenza
A102	MEDDRA-PT E24 Influenza
A103	MEDDRA-PT-ID E24 10022000
A104	CUI E25 C0548823
A105	UMLS-Preferred-Name E25 Distress gastrointestinal
A106	MEDDRA-PT E25 Abdominal discomfort
A107	MEDDRA-PT-ID E25 10000059
A108	LLT E25 Distress gastrointestinal
A109	LLT-ID E25 10013491
A110	CUI E26 C0011991
A111	UMLS-Preferred-Name E26 Diarrhea
A112	MEDDRA-PT E26 Diarrhoea
A113	MEDDRA-PT-ID E26 10012735
A114	LLT E26 Diarrhea
A115	LLT-ID E26 10012727
A116	CUI E27 C0027497
A117	UMLS-Preferred-Name E27 Nausea
A118	MEDDRA-PT E27 Nausea
A119	MEDDRA-PT-ID E27 10028813
A120	CUI E28 C0426576
A121	UMLS-Preferred-Name E28 Gastrointestinal symptom
A122	MEDDRA-PT E28 Gastrointestinal disorder
A123	MEDDRA-PT-ID E28 10017944
A124	LLT E28 Gastrointestinal symptom NOS
A125	LLT-ID E28 10018011
A126	CUI E29 C0042963
A127	UMLS-Preferred-Name E29 Vomiting
A128	MEDDRA-PT E29 Vomiting
A129	MEDDRA-PT-ID E29 10047700
A130	CUI E30 C0017168
A131	UMLS-Preferred-Name E30 Gastroesophageal reflux disease
A132	MEDDRA-PT E30 Gastrooesophageal reflux disease
A133	MEDDRA-PT-ID E30 10017885
A134	LLT E30 Gastroesophageal reflux disease
A135	LLT-ID E30 10066874
A136	CUI E31 C0013395
A137	UMLS-Preferred-Name E31 Dyspepsia
A138	MEDDRA-PT E31 Dyspepsia
A139	MEDDRA-PT-ID E31 10013946
A140	CUI E32 C0009806
A141	UMLS-Preferred-Name E32 Constipation
A142	MEDDRA-PT E32 Constipation
A143	MEDDRA-PT-ID E32 10010774
A144	CUI E38 C0542184
A145	UMLS-Preferred-Name E38 Reaction gastrointestinal
A146	MEDDRA-PT E38 Gastrointestinal disorder
A147	MEDDRA-PT-ID E38 10017944
A148	LLT E38 Reaction gastrointestinal
A149	LLT-ID E38 10037947
A150	CUI E39 C0426576
A151	UMLS-Preferred-Name E39 Gastrointestinal symptom
A152	MEDDRA-PT E39 Gastrointestinal disorder
A153	MEDDRA-PT-ID E39 10017944
A154	LLT E39 Gastrointestinal symptom NOS
A155	LLT-ID E39 10018011
A156	CUI E40 C0151735
A157	UMLS-Preferred-Name E40 Injection site reaction
A158	MEDDRA-PT E40 Injection site reaction
A159	MEDDRA-PT-ID E40 10022095
A160	CUI E41 C0151735
A161	UMLS-Preferred-Name E41 Injection site reaction
A162	MEDDRA-PT E41 Injection site reaction
A163	MEDDRA-PT-ID E41 10022095
A164	CUI E42 C0542008
A165	UMLS-Preferred-Name E42 Injection site haematoma
A166	MEDDRA-PT E42 Injection site haematoma
A167	MEDDRA-PT-ID E42 10022066
A168	LLT E42 Injection site hematoma
A169	LLT-ID E42 10055371
A170	CUI E43 C0852625
A171	UMLS-Preferred-Name E43 Injection site erythema
A172	MEDDRA-PT E43 Injection site erythema
A173	MEDDRA-PT-ID E43 10022061
A174	CUI E44 C0521505
A175	UMLS-Preferred-Name E44 Injection site dermatitis
A176	MEDDRA-PT E44 Injection site rash
A177	MEDDRA-PT-ID E44 10022094
A178	CUI E45 C0151726
A179	UMLS-Preferred-Name E45 Injection site hypersensitivity
A180	MEDDRA-PT E45 Injection site hypersensitivity
A181	MEDDRA-PT-ID E45 10022071
A182	CUI E46 C0151698
A183	UMLS-Preferred-Name E46 Injection site hemorrhage
A184	MEDDRA-PT E46 Injection site haemorrhage
A185	MEDDRA-PT-ID E46 10022067
A186	LLT E46 Injection site hemorrhage
A187	LLT-ID E46 10022068
A188	CUI E47 C0852995
A189	UMLS-Preferred-Name E47 Injection site pruritus
A190	MEDDRA-PT E47 Injection site pruritus
A191	MEDDRA-PT-ID E47 10022093
A192	CUI E48 C0151735
A193	UMLS-Preferred-Name E48 Injection site reaction
A194	MEDDRA-PT E48 Injection site reaction
A195	MEDDRA-PT-ID E48 10022095
A196	CUI E51 C0151735
A197	UMLS-Preferred-Name E51 Injection site reaction
A198	MEDDRA-PT E51 Injection site reaction
A199	MEDDRA-PT-ID E51 10022095
A200	CUI E52 C0020615
A201	UMLS-Preferred-Name E52 Hypoglycemia
A202	MEDDRA-PT E52 Hypoglycaemia
A203	MEDDRA-PT-ID E52 10020993
A204	LLT E52 Hypoglycemia
A205	LLT-ID E52 10021005
A206	CUI E53 C0020615
A207	UMLS-Preferred-Name E53 Hypoglycemia
A208	MEDDRA-PT E53 Hypoglycaemia
A209	MEDDRA-PT-ID E53 10020993
A210	LLT E53 Hypoglycemia
A211	LLT-ID E53 10021005
A212	CUI E54 C0745153
A213	UMLS-Preferred-Name E54 Hypoglycaemic episode
A214	MEDDRA-PT E54 Hypoglycaemia
A215	MEDDRA-PT-ID E54 10020993
A216	LLT E54 Hypoglycemic episode
A217	LLT-ID E54 10049635
A218	CUI E55 C0745153
A219	UMLS-Preferred-Name E55 Hypoglycaemic episode
A220	MEDDRA-PT E55 Hypoglycaemia
A221	MEDDRA-PT-ID E55 10020993
A222	LLT E55 Hypoglycemic episode
A223	LLT-ID E55 10049635
A224	CUI E57 C0020615
A225	UMLS-Preferred-Name E57 Hypoglycemia
A226	MEDDRA-PT E57 Hypoglycaemia
A227	MEDDRA-PT-ID E57 10020993
A228	LLT E57 Hypoglycemia
A229	LLT-ID E57 10021005
A230	CUI E58 C0020615
A231	UMLS-Preferred-Name E58 Hypoglycemia
A232	MEDDRA-PT E58 Hypoglycaemia
A233	MEDDRA-PT-ID E58 10020993
A234	LLT E58 Hypoglycemia
A235	LLT-ID E58 10021005
A236	CUI E62 C0020615
A237	UMLS-Preferred-Name E62 Hypoglycemia
A238	MEDDRA-PT E62 Hypoglycaemia
A239	MEDDRA-PT-ID E62 10020993
A240	CUI E63 C0860802
A241	UMLS-Preferred-Name E63 Plasma glucose decreased
A242	MEDDRA-PT E63 Blood glucose decreased
A243	MEDDRA-PT-ID E63 10005555
A244	LLT E63 Plasma glucose decreased
A245	LLT-ID E63 10035305
A246	CUI E64 C0020615
A247	UMLS-Preferred-Name E64 Hypoglycemia
A248	MEDDRA-PT E64 Hypoglycaemia
A249	MEDDRA-PT-ID E64 10020993
A250	LLT E64 Hypoglycemia
A251	LLT-ID E64 10021005
A252	CUI E65 C0032285
A253	UMLS-Preferred-Name E65 Pneumonia
A254	MEDDRA-PT E65 Pneumonia
A255	MEDDRA-PT-ID E65 10035664
A256	CUI E66 C0032285
A257	UMLS-Preferred-Name E66 Pneumonia
A258	MEDDRA-PT E66 Pneumonia
A259	MEDDRA-PT-ID E66 10035664
A260	CUI E68 C0004238
A261	UMLS-Preferred-Name E68 Atrial Fibrillation
A262	MEDDRA-PT E68 Atrial fibrillation
A263	MEDDRA-PT-ID E68 10003658
A264	CUI E69 C0004239
A265	UMLS-Preferred-Name E69 Atrial Flutter
A266	MEDDRA-PT E69 Atrial flutter
A267	MEDDRA-PT-ID E69 10003662
A268	CUI E70 C0003615
A269	UMLS-Preferred-Name E70 Appendicitis
A270	MEDDRA-PT E70 Appendicitis
A271	MEDDRA-PT-ID E70 10003011
A272	CUI E72 C0151905
A273	UMLS-Preferred-Name E72 Alanine aminotransferase increased
A274	MEDDRA-PT E72 Alanine aminotransferase increased
A275	MEDDRA-PT-ID E72 10001551
A276	LLT E72 Alanine aminotransferase increase
A277	LLT-ID E72 10001550
A278	CUI E73 C0151905
A279	UMLS-Preferred-Name E73 Alanine aminotransferase increased
A280	MEDDRA-PT E73 Alanine aminotransferase increased
A281	MEDDRA-PT-ID E73 10001551
A282	LLT E73 ALT increased
A283	LLT-ID E73 10001845
A284	CUI E74 C0151905
A285	UMLS-Preferred-Name E74 Alanine aminotransferase increased
A286	MEDDRA-PT E74 Alanine aminotransferase increased
A287	MEDDRA-PT-ID E74 10001551
A288	LLT E74 ALT increased
A289	LLT-ID E74 10001845
A290	CUI E75 C0741494
A291	UMLS-Preferred-Name E75 Elevated total bilirubin
A292	MEDDRA-PT E75 Blood bilirubin increased
A293	MEDDRA-PT-ID E75 10005364
A294	LLT E75 Bilirubin total increased
A295	LLT-ID E75 10056806
A296	CUI E76 C0151763
A297	UMLS-Preferred-Name E76 Liver damage
A298	MEDDRA-PT E76 Hepatocellular injury
A299	MEDDRA-PT-ID E76 10019837
A300	CUI E77 C0151662
A301	UMLS-Preferred-Name E77 Gamma-glutamyl transferase raised
A302	MEDDRA-PT E77 Gamma-glutamyltransferase increased
A303	MEDDRA-PT-ID E77 10017693
A304	LLT E77 GGT increased
A305	LLT-ID E77 10056910
A306	CUI E78 C0039231
A307	UMLS-Preferred-Name E78 Tachycardia
A308	MEDDRA-PT E78 Heart rate increased
A309	MEDDRA-PT-ID E78 10019303
A310	CUI E79 C0039231
A311	UMLS-Preferred-Name E79 Tachycardia
A312	MEDDRA-PT E79 Heart rate increased
A313	MEDDRA-PT-ID E79 10019303
A314	CUI E33 C0151735
A315	UMLS-Preferred-Name E33 Injection site reaction
A316	MEDDRA-PT E33 Injection site reaction
A317	MEDDRA-PT-ID E33 10022095
A318	CUI E37 C0151735
A319	UMLS-Preferred-Name E37 Injection site reaction
A320	MEDDRA-PT E37 Injection site reaction
A321	MEDDRA-PT-ID E37 10022095
A322	CUI E82 C0151905
A323	UMLS-Preferred-Name E82 Alanine aminotransferase increased
A324	MEDDRA-PT E82 Alanine aminotransferase increased
A325	MEDDRA-PT-ID E82 10001551
A326	LLT E82 ALT increased
A327	LLT-ID E82 10001845
A328	CUI E83 C0235996
A329	UMLS-Preferred-Name E83 Elevated liver enzymes
A330	MEDDRA-PT E83 Hepatic enzyme increased
A331	MEDDRA-PT-ID E83 10060795
A332	LLT E83 Raised liver enzymes
A333	LLT-ID E83 10037823
